Regulatory functions of protein kinase C isoenzymes in glomerular mesangial cells by Pfeilschifter, J. M.
Nephrol Dial Transplant (1994) 9: 1061-1062
Editorial Comment
Nephroloqy
Dialysis
Transplantation
Regulatory functions of protein kinase C isoenzymes in glomerular
mesangial cells
Prof. J. M. Pfeilschifter
Department of Pharmacology, Biocenter, University of Basel, Basel, Switzerland
Protein kinase C (PKC) is a family of isoenzymes that
are activated by hormone-stimulated phosphoinositide
and phosphatidylcholine hydrolysis and participate in
the signalling process by phosphorylating certain target
proteins. The sustained activation of PKC seems to be
essential for maintaining cellular responses such as cell
growth and differentiation. PKC also plays a pivotal
role in the pathogenesis of inflammation, and activa-
tion of PKC by phorbol esters causes all major signs
of inflammation including redness, heat, swelling and
pain. The contribution of individual PKC isoenzymes
to these processes is still ill defined.
The mesangium is a highly specialized pericapillary
tissue that is involved in most pathological processes
of the renal glomerulus. The cross-talk between
intrinsic glomerular cells and invading macrophages
and T-cells is of central importance in the pathogenesis
of glomerular injury. The progress of in-vitro cell
culture techniques, particularly with regard to the
glomerular mesangial cells, has greatly promoted our
understanding of the relevant pathomechanisms.
Three prominent proinflammatory features of in-
trinsic mesangial cells evolve as a result of the
cross-communication with invading immune cells:
(a) increased eicosanoid and other mediator produc-
tion, (b) increased matrix production by mesangial
cells, and (c) increased mesangial cell proliferation.
We have used rat glomerular mesangial cells to study
two major control functions exerted by PKC: the
regulation of hormone-stimulated prostaglandin syn-
thesis and the negative feedback regulation of the
inositol lipid signalling cascade [1]. Using specific
antibodies for PKC isoenzymes, we compared the time
courses of down-regulation of isoenzymes and func-
tional cell responses. We observed that mesangial cells
express four PKC isoenzymes, PKC-ot, -5, -e and £.
Neither PKC-0, -y or -t] were detected [2-5]. Our
experimental data led us to suggest that PKC-a
mediates feedback inhibition of phosphoinositide
hydrolysis, whereas PKC-8 is a candidate for stimulat-
ing PLA2.
One important next step is the identification of the
physiological substrates for PKC that mediate the
observed cellular functions. The cellular target of PKC
action responsible for the inhibition of angiotensin-II-
stimujated IP3 generation is not precisely known.
However, there is evidence suggesting that the coupling
between the angiotensin II receptor and the transduc-
ing G protein might be impaired [6].
The hormone-induced release of arachidonic acid
from membrane lipids is the rate-limiting step in the
synthesis of eicosanoids. The dominant factor regulat-
ing arachidonic acid liberation in most cells, including
mesangial cells, is phospholipase A2 (PLA2). Two
types of PLA2 have been described in mesangial cells.
One type is a low-molecular-mass (14kDa) PLA2
belonging to group II of the secretory PLA2 (sPLA2)
that is induced and secreted from the cells upon
stimulation with proinflammatory cytokines, such as
interleukin 1 or tumour necrosis factor a [7]. Mesangial
cells contain an additional PLA2 that shows an appar-
ent molecular mass of HOkDa upon SDS/PAGE.
Most interesting is the fact that the activity of the
latter enzyme can be increased by preincubation of the
cells with vasopressin or phorbol ester, indicating that
this is a hormone-sensitive cellular PLA2 (cPLA2) and
that PKC can increase its activity.
The presence of potential phosphorylation sites for
PKC in the sequence of cPLA2, but not sPLA2, indicate
that the former enzyme might be phosphorylated by
PKC-e in mesangial cells. A selective inhibitor for
PKC-e is therefore expected to act as a functional
cPLA2 inhibitor and to suppress formation of proin-
flammatory eicosanoids and PAF. The endogenous
activator of PKC, DAG, has an extremely short half-
life due to rapid metabolism. We have recorded a
biphasic sustained rise in DAG formation in mesangial
cells during stimulation with angiotensin II, platelet-
derived growth factor or extracellular nucleotides. The
source of DAG produced during the later phases of
hormone stimulation are derived from a substantial
breakdown of phosphatidylcholine by a phospholipase
D [8,9] and may contribute to a sustained activation
of PKC. Phorbol esters, which can activate PKC, are
able to stimulate PLD-mediated phophatidylcholine
degradation in mesangial cells. Furthermore, down-
regulation of PKC eliminates angiotensin-II- and ATP-
stimulated phophatidylcholine breakdown, thus sug-
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gesting that PKC-e is a candidate for triggering phos-
pholipase D activation in mesangial cells [8,9]. PKC-£
activation of phospholipase D may provide a possible
positive feedback loop on PKC regulation and may
trigger long-term cell responses, e.g. mesangial cell
proliferation.
The mesangial cell in culture provides an excellently
characterized cell culture system with well-known sig-
nalling pathways. Functional identification of PKC
isoenzymes involved in specific cell responses is one of
the most promising steps towards understanding of
the molecular mechanisms of cell regulation. So far,
rational drug design targeted towards PKC has mainly
focused on the association between PKC activation
and growth modulation, and PKC was considered as
a target for new anticancer drugs. However, PKC is
also a crucial regulator of proinflammatory cellular
processes and thus may become a target for anti-
inflammatory therapy. This may lead to the develop-
ment and design of potent, isoenzyme-specific inhib-
itors of PKC for the treatment of glomerulonephritis
and other inflammatory and autoimmune diseases.
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